November 28, 2011 - The Harte Group enhances the working relationship between sponsors and CROs

The Harte Group assists small to medium-sized companies when working with Contract Research Organizations.  Sponsors lean on The Harte Group to better manage and oversee Contract Research Organizations to ensure performance and quality of services provided, as well as making the appropriate selection of the right vendor for your organization and trial needs.

October 20, 2010 - The Harte Group to exhibit at the upcoming Biotech 2010 Conference in Philadelphia, PA USA

The Harte Group will attend and exhibit at the upcoming Biotech 2010 Conference, a premier biotechnology annual conference held at the Pennsylvania Convention Center on October 27-28.  Exhibits are open from 1 - 9 pm on October 28th.

April 15, 2010 - Harte Group and QED form global partnership to support clients who wish to leverage Functional Service Providers through a single source

Harte Group President Michael Harte and QED Clinical Services Ltd. Managing Director Thomas Ogorka have joined forces to offer a streamlined, high quality approach to assist sponsors with clinical trial execution using an array of vendors and consultants.  The execution will be managed from a single source and, together, provide access to an expansive suite of niche providers who are expert in their craft.

April 5, 2010 - Harte Group President, Michael Harte, highlighted in PharmaVoice magazine as a Thought Leader on the subject of Specialty CROs

Harte is a contributor to the article discussing trends in the industry, the needs of sponsors to become more virtual in their business, and the need to lean on a core team of experienced industry veterans to select and manage the appropriate groups to execute clinical trials.  In addition, sponsors will expect ransparency and accountability from the vendors employed.

March 30, 2010 - Harte Group President, Michael Harte, chairing a session at Association of Clinical Research Professionals

Harte to chair a session titled, "Clinical Study delivery Using Functional Service Providers", with a panel consisting of senior level executives representing major pharmaceutical, mature biotech, and start-up biotech companies.  Session will be presented at 2:00 - 4:15 pm on April 24, 2010.

March 15, 2010 - Harte Group Functional Services Model highlighted in leading industry publication

Harte speaks to Clinpage Editor, Mark Uehling, to discuss the changes in the pharmaceutical industry and the value of a more virtual services approach.

February 7, 2010 - Harte Group selected to create and implement a process workflow for Investigator Initiated Research programs

Harte Group has been selected by a leading pharmaceutical company to re-engineer its process regarding Investigator Initiated Studies.  Utilizing highly experienced staff and leveraging novel technologies, Harte Group has outlined and implemented a workflow which considers the many regulatory changes and internal pharmaceutical company workflow.  Sponsor comment: "Your team delivered a high quality product which exceeded our expectations."

November 5, 2009 - Harte quoted as a topic expert regarding innovation

Harte Group President Michael Harte contributes to article regarding innovation and strategies for change in the pharmaceutical industry, as well as pursuit of a newer business model.

June 8, 2009 - Harte Group model highlighted in CenterWatch Weekly

Harte Group President Michael Harte chats one-on-one with CenterWatch Senior Editor Sara Gambrill to discuss the changes in the industry related to clinical development support and use of vendor services, highlighting the use of a functional service provider model.

July  3, 2008 - Michael Harte selected to PharmaVoice 100, recognized as a Change Agent

Harte selected as one of the Top 100 Most Inspriring People in the pharmaceutical industry, as selected by industry peers.  Harte was recognized for being a Change Agent by assisting the industry with expanded use of electronic data collection technologies.

June 2, 2008 - Harte comments on the Changes within Clinical Operations and the use of technology

Michael Harte is quoted on his opinions as it relates to the changing landscape of clinical trial operations, metrics, and technology use.

January 14, 2009 - Harte Group formed to exploit the expanded use of Functional Service Providers

Harte speaks to Clinpage Editor, Mark Uehling, about his company and the use of niche providers for supporting clinical trials.